Femasys

NEWS

Pictured: IVF collage/Nicole Bean for BioSpace

Policy

Alabama Ruling, Political Blowback Rattle In Vitro Fertilization Market

A controversial decision by the Alabama Supreme Court temporarily chilled IVF before igniting nationwide pushes to protect access to this type of fertility treatment, leaving drugmakers with questions.

March 12, 2024

5 min read

Neil Versel

IN THE PRESS

Femasys’ FemCath Intrauterine Catheter Receives Product Approval in Canada

June 8, 2023

5 min read

Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

May 11, 2023

4 min read

Femasys’ FemCerv Endocervical Tissue Sampler for Cervical Cancer Diagnosis Receives Product Approval in Canada

May 3, 2023

4 min read

Femasys Inc. to Showcase FemCerv at the Annual Meeting for the American Society for Colposcopy and Cervical Pathology

May 1, 2023

3 min read

Femasys’ FemaSeed Localized Directional Insemination for Infertility Receives Product Approval in Canada

April 18, 2023

4 min read

Business

Femasys Inc. Announces Financial Results for the Year Ended December 31, 2022 and Provides Corporate Update

March 30, 2023

14 min read

BioMidwest

Femasys Inc. to Participate in “The Post-Roe Fertility Journey” Panel Discussion at SXSW 2023

March 9, 2023

1 min read

Femasys Inc. Announces Commercial Availability of its FemCath Intrauterine Device

December 19, 2022

4 min read

Femasys Inc. Reports Encouraging Promotional Launch of FemCerv at AAGL Based on Positive Reception by Gynecologic Physicians and Surgeons

December 12, 2022

6 min read

Femasys Inc. Announces Enrollment is over 25% Complete for FemaSeed® De Novo Trial Following Updated Strategic Study Design

November 29, 2022

5 min read

AWARDS

JOBS